Waddell & Reed Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $300M | Buy |
1,396,827
+10
| +0% | +$2.2K | 0.62% | 33 |
|
|
2020
Q4 | $330M | Sell |
1,396,817
-343,440
| -20% | -$78.8M | 0.7% | 28 |
|
|
2020
Q3 | $474M | Sell |
1,740,257
-18,171
| -1% | -$5.01M | 1.14% | 9 |
|
|
2020
Q2 | $510M | Sell |
1,758,428
-304,949
| -15% | -$82.7M | 1.32% | 7 |
|
|
2020
Q1 | $491M | Sell |
2,063,377
-243,878
| -11% | -$55.9M | 1.6% | 7 |
|
|
2019
Q4 | $505M | Buy |
2,307,255
+67,781
| +3% | +$13.7M | 1.25% | 8 |
|
|
2019
Q3 | $379M | Buy |
2,239,474
+4,829
| +0.2% | +$854K | 0.98% | 19 |
|
|
2019
Q2 | $410M | Buy |
2,234,645
+133,930
| +6% | +$23.4M | 1.01% | 17 |
|
|
2019
Q1 | $386M | Sell |
2,100,715
-70,342
| -3% | -$13M | 0.96% | 17 |
|
|
2018
Q4 | $360M | Sell |
2,171,057
-37,421
| -2% | -$6.48M | 1.02% | 14 |
|
|
2018
Q3 | $426M | Sell |
2,208,478
-19,877
| -0.9% | -$3.54M | 0.94% | 18 |
|
|
2018
Q2 | $379M | Sell |
2,228,355
-132,591
| -6% | -$20.6M | 0.88% | 22 |
|
|
2018
Q1 | $385M | Sell |
2,360,946
-497,901
| -17% | -$81.3M | 0.87% | 22 |
|
|
2017
Q4 | $428M | Sell |
2,858,847
-741,394
| -21% | -$110M | 0.95% | 18 |
|
|
2017
Q3 | $547M | Sell |
3,600,241
-426,182
| -11% | -$64.1M | 1.22% | 13 |
|
|
2017
Q2 | $519M | Buy |
4,026,423
+392,420
| +11% | +$47.2M | 1.14% | 15 |
|
|
2017
Q1 | $397M | Sell |
3,634,003
-214,602
| -6% | -$18.9M | 0.85% | 25 |
|
|
2016
Q4 | $284M | Sell |
3,848,605
-193,243
| -5% | -$15.7M | 0.62% | 41 |
|
|
2016
Q3 | $352M | Sell |
4,041,848
-216,630
| -5% | -$20.5M | 0.73% | 32 |
|
|
2016
Q2 | $366M | Sell |
4,258,478
-303,165
| -7% | -$26.2M | 0.77% | 31 |
|
|
2016
Q1 | $363M | Sell |
4,561,643
-426,120
| -9% | -$38.5M | 0.68% | 36 |
|
|
2015
Q4 | $628M | Buy |
4,987,763
+36,873
| +0.7% | +$4.45M | 1.02% | 21 |
|
|
2015
Q3 | $516M | Buy |
4,950,890
+215,016
| +5% | +$27.6M | 0.85% | 28 |
|
|
2015
Q2 | $585M | Buy |
4,735,874
+518,486
| +12% | +$65.3M | 0.84% | 32 |
|
|
2015
Q1 | $498M | Buy |
4,217,388
+385,088
| +10% | +$46.1M | 0.69% | 41 |
|
|
2014
Q4 | $455M | Sell |
3,832,300
-4,700
| -0.1% | -$529K | 0.63% | 46 |
|
|
2014
Q3 | $431M | Buy |
3,837,000
+28,200
| +0.7% | +$2.68M | 0.6% | 55 |
|
|
2014
Q2 | $361M | Buy |
3,808,800
+199,800
| +6% | +$14M | 0.53% | 63 |
|
|
2014
Q1 | $255M | Buy |
3,609,000
+43,300
| +1% | +$3.43M | 0.39% | 74 |
|
|
2013
Q4 | $265M | Buy |
3,565,700
+387,100
| +12% | +$27M | 0.43% | 69 |
|
|
2013
Q3 | $241M | Buy |
3,178,600
+267,500
| +9% | +$21.3M | 0.46% | 61 |
|
|
2013
Q2 | $233M | Buy |
+2,911,100
| New | +$214M | 0.49% | 57 |
|
Other funds holding VRTX
